Last reviewed · How we verify
NCT03793933
ACS-NSQIP Calculator for Liver Surgery
trial testing Liver resection in Liver Surgery in 450 participants. Completed in 1 January 2019.
1 July 2018
Quick facts
| Lead sponsor | Humanitas Clinical and Research Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 450 |
| Start date | 1 November 2015 |
| Primary completion | 1 July 2018 |
| Estimated completion | 1 January 2019 |
Drugs / interventions tested
- Liver resection
Conditions studied
- Liver Surgery — all drugs for Liver Surgery →
- Hepatectomy — all drugs for Hepatectomy →
- Outcome After Hepatectomy — all drugs for Outcome After Hepatectomy →
Sponsor
Humanitas Clinical and Research Center
Who can join
Adults 18 to 90, any sex, with Liver Surgery or Hepatectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The American College of Surgeons National Surgical Quality Improvement Program's (ACS-NSQIP) calculator has been endorsed by the surgeons' community to counsel patients and relatives regarding estimated postoperative complications. However, it does not include organ-specific risks. The aim of this study was to assess the ACS-NSQIP calculator's ability to predict complications, mortality and length of stay (LOS) in patients undergoing hepatectomy for liver tumors
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03793933
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Liver resection
Trials testing the same drug.
- NCT06420440 — Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model · Phase 2 · recruiting
- NCT05458115 — Clinical Study of MRD Recurrence Monitoring After Surgical Resection of Hepatocellular Carcinoma · unknown
- NCT05540925 — Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer · completed
- NCT06248528 — Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy. · NA · active not recruiting
- NCT04178759 — Impact of Chemotherapy and Regenerative Markers of Liver Regeneration After Liver Resection for Liver Metastases · NA · unknown
Other recruiting trials for Liver Surgery
Currently open trials in the same condition.
- NCT07192575 — Prevention of Pulmonary Complications After Laparoscopic Liver Surgery · NA · recruiting
- NCT03270917 — ORANGE SEGMENTS: Open Versus Laparoscopic Parenchymal Preserving Postero-Superior Liver Segment Resection · NA · active not recruiting
Other Humanitas Clinical and Research Center trials
Trials by the same sponsor.
- NCT07161297 — Remimazolam for Colonoscopy in IBD Patients · Phase 4 · not yet recruiting
- NCT04934943 — "Mini Fluid Challenge Assessment: a Comparison Among Three Hemodynamic Tools" · not yet recruiting
- NCT06394947 — Fluid Challenge in Intensive Care The FENICE II Study · completed
- NCT06627907 — Hemodynamic Response to the End-expiratory Occlusion Test to Titrate Fluid Challenge in Operating Room. · not yet recruiting
- NCT06099171 — Therapy With Paravertebral Oxygen-ozone Injections and Topical Cannabidiol and β-Caryophyllene Patch in Neck Pain · Phase 3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03793933 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Humanitas Clinical and Research Center
- Last refreshed: 4 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03793933.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing